Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTRPO9Z)

DTT Name TNF-alpha signaling pathway (TNFA pathway)
Gene Name TNFA pathway
DTT Type
Clinical trial target
 [1]
BioChemical Class
Viral DNA polymerase
UniProt ID
NOUNIPROTAC
TTD ID
T29075

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
ADVAX DMH8Z9W Human immunodeficiency virus infection 1C62 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine. PLoS One. 2010 Jan 25;5(1):e8617.